Evidence map›Paper›PMID 15976333›Full record

ArticleJournal of clinical pathology2005

Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract.

B Shen, E M Porter, E Reynoso, C Shen, D Ghosh, J T Connor, J Drazba, H K Rho, T L Gramlich, R Li and 4 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of clinical pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Functional characterization of novel anti-DEFA5 monoclonal antibody clones 1A8 and 4F5 in inflammatory bowel disease colitis tissues.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  3. Human intelectin-2 (ITLN2) is selectively expressed by secretory Paneth cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Inflammatory bowel disease: an impaired barrier disease.Langenbeck's archives of surgery · 2013
    Review
  13. Article
  14. Review
  15. Antimicrobial peptides in gastrointestinal inflammation.International journal of inflammation · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. My approach to reporting a gastric biopsy.Journal of clinical pathology · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

B ShenDepartment of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
E M Porter
E Reynoso
C Shen
D Ghosh
J T Connor
J Drazba
H K Rho
T L Gramlich
R Li
A H Ormsby
M-S Sy
T Ganz
C L Bevins
Cleveland Clinic · USCalifornia State University Los Angeles · USCase Western Reserve University · USCleveland Clinic Lerner College of Medicine · USCity Hospital · GBUniversity of California, Davis · USUniversity of California, Los Angeles · US

Funding

Novel Defensins in Human Epithelial TissuesR37AI032738 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEVINS, CHARLES L · 2015 to 2022
$3.1M
Novel Defensins of Human EpitheliaR01AI032738 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BEVINS, CHARLES L · 1993 to 2009
$2.3M
NIAID NIH HHS AI 32738NIAID NIH HHS R01 AI032738NIAID NIH HHS R37 AI032738
6 · The paper itself

Abstract

backgroundUpper gastrointestinal tract intestinal metaplasia (IM) is termed Barrett's oesophagus (BO) or gastric intestinal metaplasia (GIM), depending on its location. BO and GIM are associated with chemical exposure resulting from gastro-oesophageal reflux and chronic Helicobacter pylori infection, respectively. Paneth cells (PCs), characterised by cytoplasmic eosinophilic granules, are found in a subset of IM at these sites, but histology may not accurately detect them.

aimTo determine human defensin 5 (HD5; an antimicrobial peptide produced by PCs) expression in BO and GIM, and to investigate its association with H pylori infection.

methodsEndoscopic biopsies from 33 patients with BO and 51 with GIM, and control tissues, were examined by routine histology and for H pylori infection and HD5 mRNA and protein expression.

resultsIn normal tissues, HD5 expression was specific for PCs in the small intestine. Five patients with BE and 42 with GIM expressed HD5, but few HD5 expressing cells in IM had the characteristic histological features of PCs. Most HD5 positive specimens were H pylori infected and most HD5 negative specimens were not infected.

conclusionsHD5 immunohistochemistry was often positive in IM when PCs were absent by conventional histology. Thus, HD5 immunohistochemistry may be superior to histology for identifying metaplastic PCs and distinguishing GIM from BO. The higher frequency of HD5 expression in GIM than in BO is associated with a higher frequency of H pylori infection, suggesting that in IM PCs may form part of the mucosal antibacterial response.

Indexed as

AdultAgedBarrett EsophagusBlotting, WesternDefensinsEnzyme-Linked Immunosorbent AssayEsophagogastric JunctionFemaleGastric MucosaGene ExpressionHelicobacter InfectionsHelicobacter pyloriHumansMaleMetaplasiaMiddle AgedDefensinsRNA, Messenger

Identifiers

PMID15976333
PMCPMC1770712
OpenAlexW2108154513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.